UK markets closed

The Brink's Company (BCO)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
97.71-0.29 (-0.29%)
As of 03:03PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.36B
Enterprise value 7.09B
Trailing P/E 37.40
Forward P/E 15.90
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.92
Price/book (mrq)10.99
Enterprise value/revenue 1.44
Enterprise value/EBITDA 9.20

Trading information

Stock price history

Beta (5Y monthly) 1.39
52-week change 346.77%
S&P500 52-week change 326.16%
52-week high 398.99
52-week low 363.79
50-day moving average 388.52
200-day moving average 380.17

Share statistics

Avg vol (3-month) 3234.79k
Avg vol (10-day) 3310.83k
Shares outstanding 544.46M
Implied shares outstanding 644.72M
Float 843.27M
% held by insiders 12.06%
% held by institutions 199.28%
Shares short (30 Apr 2024) 41M
Short ratio (30 Apr 2024) 45.39
Short % of float (30 Apr 2024) 43.41%
Short % of shares outstanding (30 Apr 2024) 42.25%
Shares short (prior month 28 Mar 2024) 41.05M

Dividends & splits

Forward annual dividend rate 40.96
Forward annual dividend yield 40.98%
Trailing annual dividend rate 30.88
Trailing annual dividend yield 30.90%
5-year average dividend yield 41.08
Payout ratio 433.59%
Dividend date 303 Jun 2024
Ex-dividend date 410 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.48%
Operating margin (ttm)8.96%

Management effectiveness

Return on assets (ttm)5.00%
Return on equity (ttm)23.33%

Income statement

Revenue (ttm)4.93B
Revenue per share (ttm)107.72
Quarterly revenue growth (yoy)4.30%
Gross profit (ttm)N/A
EBITDA 797.5M
Net income avi to common (ttm)121M
Diluted EPS (ttm)2.62
Quarterly earnings growth (yoy)228.70%

Balance sheet

Total cash (mrq)1.14B
Total cash per share (mrq)25.61
Total debt (mrq)3.85B
Total debt/equity (mrq)741.05%
Current ratio (mrq)1.46
Book value per share (mrq)8.89

Cash flow statement

Operating cash flow (ttm)811.4M
Levered free cash flow (ttm)432.5M